Positive selection of invariant V alpha 14+ T cells by non-major histocompatibility complex-encoded class I-like molecules expressed on bone marrow-derived cells.
about
Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapyMultiple immuno-regulatory defects in type-1 diabetesIL-12 and IL-18 induction and subsequent NKT activation effects of the Japanese botanical medicine Juzentaihoto.Differential pathogenesis of lethal mousepox in congenic DBA/2 mice implicates natural killer cell receptor NKR-P1 in necrotizing hepatitis and the fifth component of complement in recruitment of circulating leukocytes to spleen.Generation of NK1.1+ T cell antigen receptor alpha/beta+ thymocytes associated with intact thymic structureIntrathymic selection of NK1.1(+)alpha/beta T cell antigen receptor (TCR)+ cells in transgenic mice bearing TCR specific for chicken ovalbumin and restricted to I-Ad.Identification of novel lymphoid tissues in murine intestinal mucosa where clusters of c-kit+ IL-7R+ Thy1+ lympho-hemopoietic progenitors developExpansion of natural (NK1+) T cells that express alpha beta T cell receptors in transporters associated with antigen presentation-1 null and thymus leukemia antigen positive mice.A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage.A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus.Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cellsRegulation of experimental autoimmune encephalomyelitis by natural killer (NK) cellsInduction of differentiation of pre-NKT cells to mature Valpha14 NKT cells by granulocyte/macrophage colony-stimulating factorDevelopmentally regulated extinction of Ly-49 receptor expression permits maturation and selection of NK1.1+ T cellsCD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolutionEssential requirement of an invariant V alpha 14 T cell antigen receptor expression in the development of natural killer T cellsNKT cells as an ideal anti-tumor immunotherapeuticDevelopment of Valpha4+ NK T cells in the early stages of embryogenesis.The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy.Immunotherapeutic strategies targeting natural killer T cell responses in cancer.NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function.Interleukin-12 as an inducer of cytotoxic effectors in anti-tumor immunity.Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells.Stringent V beta requirement for the development of NK1.1+ T cell receptor-alpha/beta+ cells in mouse liver.Malaria protection in beta 2-microglobulin-deficient mice lacking major histocompatibility complex class I antigens: essential role of innate immunity, including gammadelta T cells.Resistance of extrathymic T cells to stress and the role of endogenous glucocorticoids in stress associated immunosuppression.
P2860
Q26801584-0287C76A-35F1-45D0-BB81-2469F650AF42Q28344695-F4F034E3-A331-48FA-9F02-5A4E56B4FB36Q33422912-DF110DBE-6AFE-4E7A-8F7C-10BF5829A3C4Q35764260-3DD0550A-8E0A-49A3-823F-21A81D7BBA1CQ36047199-2386BA28-8C98-4C21-ACF2-04B5DD00A09AQ36171793-3C646792-3A55-45E4-AF0B-69474E82687FQ36367413-59B527EE-B237-4F61-AEAF-5923C8EDAFE2Q36367491-9AE29026-A6E2-403A-B96D-2D20949EB4E7Q36370202-9AFAE043-2FE1-4527-832B-7687A6ECA944Q36375356-5B6CA330-1C9B-4EBE-8420-8F23DC50CB80Q36380304-27085A7A-BE65-4D6B-8943-870CB3AE1589Q36380889-0241E8A9-FADC-4735-B815-BC555BE21341Q36396689-2B55B280-055E-4D87-90F6-07B2843AEAAFQ36401109-1B17F723-0391-43B7-A001-C27E52C33426Q36404242-76D9EE94-183E-4BCE-879A-BC5207196290Q37307519-99DCA965-94FB-4FFF-9D58-3516C0146473Q37352756-3C132C44-45BA-4C0B-A790-218FF77C9E9BQ37527374-49F6E4E3-28B3-4F6F-A1F2-5E1440D5F803Q37621786-6DCDCACB-B1C9-4A23-9F25-1935998DFF7EQ38890717-8AC19143-95A1-4C2D-80C6-D2D6DF80F58AQ40468611-E5F47F5F-E690-4C3B-B6DE-6F01B104C873Q41455948-A47693D7-3A6D-4412-B3E4-58CCE61792C7Q41837371-D4753611-F0EA-41EA-AD3C-979B61160AA8Q41941186-1113FB2B-3405-40BF-BC9A-F77B86488B8BQ47845753-C921C417-E197-4E41-BEAA-B35B4AD239F5Q54057761-6775A9D4-7558-417C-AA33-8817C911C8BF
P2860
Positive selection of invariant V alpha 14+ T cells by non-major histocompatibility complex-encoded class I-like molecules expressed on bone marrow-derived cells.
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Positive selection of invarian ...... on bone marrow-derived cells.
@ast
Positive selection of invarian ...... on bone marrow-derived cells.
@en
Positive selection of invarian ...... on bone marrow-derived cells.
@nl
type
label
Positive selection of invarian ...... on bone marrow-derived cells.
@ast
Positive selection of invarian ...... on bone marrow-derived cells.
@en
Positive selection of invarian ...... on bone marrow-derived cells.
@nl
prefLabel
Positive selection of invarian ...... on bone marrow-derived cells.
@ast
Positive selection of invarian ...... on bone marrow-derived cells.
@en
Positive selection of invarian ...... on bone marrow-derived cells.
@nl
P2093
P2860
P356
P1476
Positive selection of invarian ...... on bone marrow-derived cells.
@en
P2093
P2860
P304
P356
10.1073/PNAS.92.4.1200
P407
P577
1995-02-01T00:00:00Z